The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
150 jobs Number of planned job losses
Announcement Date
6 November 2006
Employment effect (start)
Foreseen end date
Description
US-based pharmaceutical company Eli Lilly & Co. announced on 6 November 2006 its plans to close its research laboratories at Hamburg (Germany), Mont-Saint-Guibert (Belgium) and Basingstoke (UK). Whereas there are no further data available on the Belgish and UK locations, the company announced that the closure of the Hamburg laboratory is due to the small size of the German unit and the strategic decision not to invest in its future expansion. Research activites in Germany will be limited to clinical testing of medicines. Apart from this, Eli Lilly is expanding its operations in Germany. A new head quarter is built at Bad Homburg and at Giessen a logistics center is under construction. The company currently employs 1,400 people in Germany.
Sources
6 November 2006: Frankfurter Allgemeine Zeitung
Citation
Eurofound (2006), Eli Lilly, Internal restructuring in Germany, factsheet number 64386, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/64386.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
